A mechanism for the involvement of colocalized neuropeptides in the actions of antipsychotic drugs
- 1 July 1989
- journal article
- editorial
- Published by Elsevier in Biological Psychiatry
- Vol. 26 (3) , 303-314
- https://doi.org/10.1016/0006-3223(89)90043-7
Abstract
No abstract availableThis publication has 102 references indexed in Scilit:
- Cholecystokinin potentiates dopamine inhibition of mesencephalic dopamine neurons in vitroBrain Research, 1987
- Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neuronsNeuroscience, 1984
- Effects of selective dopamine D2-receptor agonists on the release of cholecystokinin-like immunoreactivity from rat neostriatumEuropean Journal of Pharmacology, 1984
- Dopamine and schizophrenia: An analysis of the theoryNeuroscience & Biobehavioral Reviews, 1984
- Typical and atypical neuroleptics: differential effects of chronic administration on the activity of A9 and A10 midbrain dopaminergic neuronsJournal of Neuroscience, 1983
- Dendritic release of dopamine in the substantia nigraNature, 1981
- Dopamine and the Pathophysiology of Dyskinesias Induced by Antipsychotic DrugsAnnual Review of Neuroscience, 1980
- Antipsychotic Drugs, Neurotransmitters, and SchizophreniaAmerican Journal of Psychiatry, 1978
- Antischizophrenic Drugs: Chronic Treatment Elevates Dopamine Receptor Binding in BrainScience, 1977
- Hyperactivity of Remaining Dopaminergic Neurones after Partial Destruction of the Nigro-striatal Dopaminergic System in the RatNature New Biology, 1973